# Dendritic Cell Activating Scaffold in Melanoma

> **NCT01753089** · PHASE1 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 23 (actual)

## Conditions studied

- Melanoma

## Interventions

- **BIOLOGICAL:** WDVAX

## Key facts

- **NCT ID:** NCT01753089
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2025-08-04
- **Final completion:** 2025-08-04
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01753089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01753089, "Dendritic Cell Activating Scaffold in Melanoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01753089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*